Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 2
1988 1
1989 1
1990 2
1991 2
1992 3
1993 3
1994 1
1995 3
1996 2
1997 1
1998 6
1999 3
2000 2
2002 1
2003 1
2004 1
2005 1
2006 7
2007 1
2008 6
2009 6
2010 5
2011 4
2012 13
2013 8
2014 6
2015 14
2016 26
2017 27
2018 32
2019 30
2020 30
2021 36
2022 25
2023 27
2024 28
2025 50

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

354 results

Results by year

Filters applied: . Clear all
Page 1
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Vestibular Schwannomas.
Carlson ML, Link MJ. Carlson ML, et al. N Engl J Med. 2021 Apr 8;384(14):1335-1348. doi: 10.1056/NEJMra2020394. N Engl J Med. 2021. PMID: 33826821 Review. No abstract available.
Brigatinib in NF2-Related Schwannomatosis with Progressive Tumors.
Plotkin SR, Yohay KH, Nghiemphu PL, Dinh CT, Babovic-Vuksanovic D, Merker VL, Bakker A, Fell G, Trippa L, Blakeley JO; INTUITT-NF2 Consortium. Plotkin SR, et al. N Engl J Med. 2024 Jun 27;390(24):2284-2294. doi: 10.1056/NEJMoa2400985. Epub 2024 Jun 21. N Engl J Med. 2024. PMID: 38904277 Clinical Trial.
On the basis of preclinical activity of brigatinib (an inhibitor of multiple tyrosine kinases) in NF2-driven nonvestibular schwannoma and meningioma, data were needed on the use of brigatinib in patients with multiple types of progressive NF2-SWN tumors. ...RESULTS: A tota …
On the basis of preclinical activity of brigatinib (an inhibitor of multiple tyrosine kinases) in NF2-driven nonvestibular schwannoma …
Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas.
Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Piotrowski A, et al. Nat Genet. 2014 Feb;46(2):182-7. doi: 10.1038/ng.2855. Epub 2013 Dec 22. Nat Genet. 2014. PMID: 24362817 Free PMC article.
We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one copy of 22q, encompassing SMARCB1 and NF2, with a different somatic mutation of the other NF2 allele in every schwannoma but no mutati …
We sequenced highly conserved regions along 22q from eight individuals with schwannomatosis whose schwannomas involved somatic loss of one c …
Intralabyrinthine schwannomas.
Frisch CD, Eckel LJ, Lane JI, Neff BA. Frisch CD, et al. Otolaryngol Clin North Am. 2015 Jun;48(3):423-41. doi: 10.1016/j.otc.2015.02.004. Epub 2015 Apr 9. Otolaryngol Clin North Am. 2015. PMID: 25863567 Review.
Pediatric Non-vestibular Schwannoma.
Broehm C, Al-Ibraheemi A, Fritchie KJ. Broehm C, et al. Pediatr Dev Pathol. 2017 Jun;20(3):232-239. doi: 10.1177/1093526617703540. Epub 2017 Apr 18. Pediatr Dev Pathol. 2017. PMID: 28420320
While the clinicopathologic features of pediatric vestibular schwannomas, often in the context of neurofibromatosis type 2 (NF2), have been well studied, there is less data regarding the characteristics of pediatric non-vestibular schwannomas (NVS). ...
While the clinicopathologic features of pediatric vestibular schwannomas, often in the context of neurofibromatosis type 2 (NF2), hav …
Vestibular Schwannomas. Reply.
Carlson ML, Link MJ. Carlson ML, et al. N Engl J Med. 2021 Jul 22;385(4):381-382. doi: 10.1056/NEJMc2108279. N Engl J Med. 2021. PMID: 34289290 No abstract available.
Medical Malpractice and Vestibular Schwannomas: A Nationwide Review.
Bader ER, Boyke A, Alvi MA, Sethi A, Funari A, Agarwal V. Bader ER, et al. World Neurosurg. 2021 Jun;150:e714-e726. doi: 10.1016/j.wneu.2021.03.093. Epub 2021 Mar 26. World Neurosurg. 2021. PMID: 33775868
OBJECTIVE: Most surgeons face litigation related to the care of their patients, with specialties including neurosurgery facing a particularly high risk. Diagnosis and management of vestibular schwannomas can be challenging, potentially giving rise to medicolegal proceeding …
OBJECTIVE: Most surgeons face litigation related to the care of their patients, with specialties including neurosurgery facing a particularl …
Radiotherapy for Growing Vestibular Schwannomas.
Sethi M, Gowrishankar S, Tysome J, Donnelly N, Axon P, Bance M, Mannion R, Guilfoyle M, Buttimore J, Gamazo N, Duke S, Jena R, Burton K, Jefferies S, Fornezza U, Perini Z, Mari C, Gazzola L, Schouten S, Compter I, Eekers DBP, Kunst HPM, Bassi R, MacKeith S, Jeyaretna S, Whitfield G, McBain C, Colaco R, Hotchkies A, Lloyd S, Obholzer R, Cheang YFA, Thomas N, Barazi S, Maratos E, Shapey J, Hassan S, Tancu C, Kitchen N, Marinelli JP, Carlson ML, Link MJ, Borsetto D. Sethi M, et al. JAMA Otolaryngol Head Neck Surg. 2025 Oct 1;151(10):931-937. doi: 10.1001/jamaoto.2025.1953. JAMA Otolaryngol Head Neck Surg. 2025. PMID: 40906473
IMPORTANCE: In the literature, there is a lack of data reporting tumor control rates after radiotherapy in actively growing vestibular schwannomas (VS). Data for this rarely studied population are needed. OBJECTIVE: To estimate tumor control rates in radiologically growing …
IMPORTANCE: In the literature, there is a lack of data reporting tumor control rates after radiotherapy in actively growing vestibular …
354 results